PROTAC technology for the treatment of Alzheimer's disease: advances and perspectives
Neurodegenerative diseases are characterized by the progression of neuronal degeneration, resulting in dysfunction of cognition and mobility. Many neurodegenerative diseases are due to proteinopathies arising from unusual protein accumulation and aggregation. The aggregation of misfolded proteins, s...
Saved in:
Main Authors: | Hiroyuki Inuzuka (Author), Jing Liu (Author), Wenyi Wei (Author), Abdol-Hossein Rezaeian (Author) |
---|---|
Format: | Book |
Published: |
Compuscript Ltd,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer's disease
by: Abdol-Hossein Rezaeian, et al.
Published: (2022) -
PROTACs targeting epigenetic proteins
by: Chao Zhang, et al.
Published: (2023) -
Application of PROTACs in target identification and validation
by: Yang Liu, et al.
Published: (2024) -
PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin ligase: an updated perspective
by: Xin Han, et al.
Published: (2022) -
Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
by: Arvind Negi, et al.
Published: (2022)